 
                        Telotristat Etiprate NEW
| Price | $61 | $93 | $153 | 
| Package | 5mg | 10mg | 25mg | 
| Min. Order: | |
| Supply Ability: | 10g | 
| Update Time: | 2025-10-27 | 
Product Details
| Product Name: Telotristat Etiprate | CAS No.: 1137608-69-5 | 
| Purity: 99.21% | Supply Ability: 10g | 
| Release date: 2025/10/27 | 
Product Introduction
Bioactivity
| Name | Telotristat Etiprate | 
| Description | Telotristat Etiprate (LX 1606 Hippurate) is an orally bioavailable, tryptophan hydroxylase (TPH) inhibitor with potential antiserotonergic activity. | 
| In vivo | Telotristat Etiprate (300 mg/kg p.o.) significantly reduces 5-HT in the gut and blood, but not brain 5-HT. Telotristat Etiprate (200 mg/kg p.o.) alleviates the severity of trinitrobenzene sulfonic acid (TNBS)-induced colitis with lower expression of some genes encoding inflammation-related cytokines and chemokines in mice. [2] | 
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | 
| Solubility Information | Ethanol : < 1 mg/mL (insoluble or slightly soluble) H2O : < 1 mg/mL (insoluble or slightly soluble) DMSO : 100 mg/mL (132.6 mM), Sonication is recommended. | 
| Keywords | Tryptophan Hydroxylase | Tryptophan hydroxylase | Telotristat Etiprate | LX-1606 | LX1606 | LX 1606 | Inhibitor | inhibit | Hippurate | 
| Inhibitors Related | p-Ethynylphenylalanine | Mildronate | Telotristat ethyl | Tetrahydropapaverine hydrochloride | Casein | p-Fluoro-L-phenylalanine | Ketoconazole | Bupicomide | Ro 61-8048 | Diethyl-pythiDC | Fenclonine | Nepicastat hydrochloride | 
| Related Compound Libraries | Failed Clinical Trials Compound Library | Bioactive Compound Library | EMA Approved Drug Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Inhibitor Library | FDA-Approved Drug Library | Anti-Cancer Approved Drug Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max | Anti-Cancer Active Compound Library | Anti-Cancer Drug Library | 
Company Profile Introduction
                            Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
                        
                    You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $1520.00/25mg | VIP2Y | TargetMol Chemicals Inc. | 2025-08-21 | |
| $15.00/1KG | Zhuozhou Wenxi import and Export Co., Ltd | 2021-07-09 | ||
| $2.00/1kg | VIP8Y | Career Henan Chemical Co | 2018-12-23 | |
| $1.00/1g | VIP6Y | Career Henan Chemical Co | 2020-02-01 | |
| $2.00/1kg | VIP8Y | Career Henan Chemical Co | 2018-12-23 | 
- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY
                    
 
            


 
                 
        
 
                                         
                                         
                                         
                                         
                             United States
United States